Biologic AI

Startup
United States
Summarized by Halo AI

Biologic AI is a biotechnology company that uses an AI-powered discovery platform to computationally design novel, patent-protected peptides that target the root molecular drivers of skin aging.

IP status
10 patents filed
Activity highlights
Filed 10 U.S. provisional patent applications across its portfolio of computationally designed peptides for skin longevity.

Biologic AI is a biotechnology company that utilizes an oncology-grade, structure-based artificial intelligence platform to computationally design novel, patent-protected peptides for skin longevity. Its discovery engine is powered by an orchestrated stack of over 40 computational tools, which are calibrated against experimental ground truth to simulate the entire validation process from target to filed intellectual property in silico, minimizing the need for initial laboratory expenditure.

By prioritizing computational discovery over traditional lab-first screening, the company develops mechanism-specific actives aimed at targeting the root molecular drivers of skin aging. This approach allows Biologic AI to generate a pipeline of proprietary compounds that can either be licensed or utilized to develop science-first, owned brands, offering a novel category of solutions in the skin health and beauty sectors.

AI summary generated on Jun 29, 2026
OpenAlexOpenAlex

For general inquiries

MS
Marc Stein
Founder
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Looking for

Sponsored researchCo-developmentLicensingPilot or trial engagement
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.